Coming Soon
The Genomic Test Requisition Review Note is a specialized template designed for clinical geneticists to meticulously document the evaluation of genomic test requests. This comprehensive template records critical information, including the review date, details of the submitting provider, specific tests requested, clinical indications, specimen information, and initial assessments. It ensures thorough documentation in compliance with clinical guidelines, enhancing accuracy and efficiency in genomic testing workflows. This template is an essential resource for geneticists and healthcare professionals, facilitating streamlined review processes and supporting high-priority genomic testing cases. Ideal for implementation in s10.ai, it optimizes the genomic testing review process, encouraging clinicians to adopt and explore its benefits.
Organized sections for comprehensive clinical documentation
Example of completed documentation using this template
Genomic Test Requisition Review NoteDate of Review:1 November 2024 - Comprehensive EvaluationSubmitting Provider and Institution:Dr. Emily Carter, MD, PhD, Genetics Department, St. Mary's Hospital, Contact: emily.carter@stmaryshospital.org, Referring Genetic Counselor: Jane Doe, MS, CGCTest Requested:Whole Exome Sequencing, Version 3.2, Laboratory Accession Number: WES-2024-00123, Clinical AssayClinical Indication:Patient exhibits developmental delay, hypotonia, and dysmorphic features. Suspected autosomal dominant inheritance. HPO terms: HP:0001263, HP:0001250. Urgent testing requested due to prenatal timeline.Specimen Details:Blood sample, arrived in optimal condition, collected on 28 October 2024, shipped within 24 hours, sample volume: 5ml, DNA yield: 50 ng/µl, chain of custody maintained.Preliminary Assessment:Requisition is complete and valid. Test choice is appropriate for clinical indication. All necessary documents, including consent forms and clinical summaries, are attached. Insurance preauthorization confirmed. Case meets institutional test eligibility guidelines.Test Approval and Processing Status:Test approved and queued for high-priority processing. Internal workflow code: HPQ-2024-EXOMEInitial Observations or Concerns:No initial concerns identified. Phenotype is consistent with requested test. No prior testing duplication noted. Consent forms are correctly matched. No pre-analytical errors suspected.
Key advantages of using this template in clinical practice
Common questions about this template and its usage